Projects
SINCE ITS INCORPORATION THE FOUNDATION HAS AGREED IN PRINCIPLE TO SUPPORT TWO INNOVATIVE PROJECTS, THE FIRST BASED IN ENGLAND AND THE SECOND IN SWITZERLAND:
A grant of £30,000 has been made to complete the funding of a £120,000 pilot project for writing new software that will allow the 4 labs involved in the lymphoma screening process to co-ordinate their results in a standard format before these are sent back to the consultant. This will enable the UK to be brought into line with mainstream EU diagnostic systems but more importantly should allow clinicians to diagnose lymphoma more accurately. Current research has shown that 1 in 3 cases in men in the UK are misdiagnosed leading to premature death or a failure to treat the right disease at the optimum time.
The project is intended to go live in the spring of 2009.
A grant of up to Swiss Francs 165,000 has been earmarked for a Project of the Swiss Group for Clinical Cancer Research. This is a Phase II multicentre study to assess the feasibility and efficacy of the drugs Clofarabine, Gemtuzumab Ozogamicin and doses of Cytarabine for the treatment of relapsed/refractory AML in young patients.
The project is expected to start in late 2009.
|
